Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -74.02% is 33% below its 5-year average of -55.76%, around the middle of its 5-year range (-116.73%–-16.23%).
As of the fiscal period ended Tuesday, June 30, 2026. 10.83% below its 12-month average of -66.78%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -74.02%.
RETURN ON INVESTED CAPITAL (ROIC)
-74.02%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-66.78%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-62.85%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-55.76%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-64.49%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-10.83%
CURRENT VS 3Y AVG
-17.77%
CURRENT VS 5Y AVG
-32.73%
CURRENT VS 10Y AVG
-14.77%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-107.65%
vs the sector median at left
Eledon Pharmaceuticals, Inc.
Market Cap
$186.79M
Return on Invested Capital (ROIC)
-74.02%
TTM Avg
-66.78%
3Y Avg
-62.85%
5Y Avg
-55.76%
Market Cap
$184.78M
Return on Invested Capital (ROIC)
-51.01%
TTM Avg
-69.12%
3Y Avg
-59.60%
5Y Avg
-89.29%
Market Cap
$191.14M
Return on Invested Capital (ROIC)
-105.17%
TTM Avg
-54.92%
3Y Avg
-54.02%
5Y Avg
-50.29%
Market Cap
$182.41M
Return on Invested Capital (ROIC)
-9.57%
TTM Avg
-477.38%
3Y Avg
-295.61%
5Y Avg
-295.61%
Market Cap
$190.97M
Return on Invested Capital (ROIC)
-20.24%
TTM Avg
-14.71%
3Y Avg
-27.01%
5Y Avg
-29.46%
Market Cap
$181.55M
Return on Invested Capital (ROIC)
-46.59%
TTM Avg
-39.23%
3Y Avg
-33.74%
5Y Avg
-53.74%
Market Cap
$180.31M
Return on Invested Capital (ROIC)
-3.21%
TTM Avg
-7.29%
3Y Avg
-11.96%
5Y Avg
-13.56%
Market Cap
$198.73M
Return on Invested Capital (ROIC)
-71.04%
TTM Avg
-53.65%
3Y Avg
-40.34%
5Y Avg
-35.55%
Market Cap
$175.95M
Return on Invested Capital (ROIC)
-90.33%
TTM Avg
-95.47%
3Y Avg
-83.14%
5Y Avg
-82.51%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | $186.79M | -74.02% | -66.78% | -62.85% | -55.76% |
| AN2 Therapeutics, Inc. (ANTX)vs › | $184.78M | -51.01% | -69.12% | -59.60% | -89.29% |
| Zentalis Pharmaceuticals, Inc. (ZNTL)vs › | $191.14M | -105.17% | -54.92% | -54.02% | -50.29% |
| Canton Strategic Holdings Inc (CNTN)vs › | $182.41M | -9.57% | -477.38% | -295.61% | -295.61% |
| RxSight, Inc. (RXST)vs › | $190.97M | -20.24% | -14.71% | -27.01% | -29.46% |
| Compass Therapeutics, Inc. (CMPX)vs › | $181.55M | -46.59% | -39.23% | -33.74% | -53.74% |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $180.31M | -3.21% | -7.29% | -11.96% | -13.56% |
| Alector, Inc. (ALEC)vs › | $198.73M | -71.04% | -53.65% | -40.34% | -35.55% |
| Yarrow Bioscience Inc (YARW)vs › | $175.95M | -90.33% | -95.47% | -83.14% | -82.51% |
| ProQR Therapeutics N.V. (PRQR)vs › | $174.81M | -42.61% | -32.20% | -32.84% | -32.70% |
ROIC
-74.0%
ROE
-136.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -74.02% |
| 2026-03-31 | -64.73% |
| 2025-12-31 | -55.26% |
| 2025-09-30 | -74.82% |
| 2025-06-30 | -65.09% |
| 2025-03-31 | -51.06% |
| 2024-12-31 | -42.56% |
| 2024-09-30 | -55.07% |
| 2024-06-30 | -40.98% |
| 2024-03-31 | -55.84% |
| 2023-12-31 | -50.49% |
| 2023-09-30 | -98.05% |
| 2023-06-30 | -89.07% |
| 2023-03-31 | -116.73% |
| 2022-12-31 | -102.44% |
| 2022-09-30 | -27.30% |
| 2022-06-30 | -25.78% |
| 2022-03-31 | -23.81% |
| 2021-12-31 | -22.19% |
| 2021-09-30 | -19.54% |
| 2021-06-30 | -16.23% |
| 2021-03-31 | -12.85% |
| 2020-12-31 | -9.48% |
| 2020-09-30 | -8.73% |
| 2020-06-30 | -138.83% |
| 2020-03-31 | -122.90% |
| 2019-12-31 | -167.04% |
| 2019-09-30 | -121.42% |
| 2019-06-30 | -104.75% |
| 2019-03-31 | -158.08% |
| 2018-12-31 | -97.02% |
| 2018-09-30 | -63.24% |
| 2018-06-30 | -51.38% |
| 2018-03-31 | -59.80% |
| 2017-12-31 | -67.45% |
| 2017-09-30 | -71.34% |
| 2017-06-30 | -56.70% |
| 2017-03-31 | -32.86% |
| 2016-12-31 | -58.54% |
| 2016-09-30 | -82.63% |
| 2016-06-30 | -90.65% |
| 2016-03-31 | -84.30% |
| 2015-12-31 | -73.22% |
| 2015-09-30 | -56.22% |
| 2015-06-30 | -42.25% |
| 2015-03-31 | -35.06% |
| 2014-12-31 | -22.67% |
| 2014-09-30 | -22.39% |
| 2014-06-30 | -99.79% |
